Nivolumab vs Zolpidem

## Nivolumab vs Zolpidem: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Zolpidem**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Zolpidem**: Selective GABA-A receptor alpha-1 subunit agonist.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Zolpidem — 2.5 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Zolpidem — C19H21N3O.

**Molecular Weight**: Nivolumab — N/A; Zolpidem — 307.3950 g/mol.

**Type**: Nivolumab — Antibody; Zolpidem — Small molecule.